Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
The impact of socioeconomic status on the management of epilepsy: a qualitative study
Jessica Spooner1, Soham Bandyopadhyay1, Mohammad Baraka2
1Clinical Neurosciences, Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK; Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Introduction:
Socioeconomic status (SES) is a recognised determinant of epilepsy outcome, yet it remains unclear whether epilepsy management is effectively contextualised to meet the needs of individuals across different SES backgrounds. This study explored how adults with epilepsy perceive the influence of SES on their care and self-management.
Methods:
In-depth, semi-structured videoconference or telephone interviews were conducted until data saturation with fifteen adults (11 women, 18-75 years) recruited through national epilepsy charities. SES was classified with the "MacArthur Subjective Social Status ladder" and "Social Determinants of Health" indicators, yielding eight low/lower‑middle ("lower‑SES") and seven upper‑middle/high ("higher‑SES") participants. Two researchers analysed transcripts inductively using reflexive thematic analysis. Member checking confirmed analytic credibility.
Results:
Eight interrelated themes emerged: support networks and relationships; financial implications and access to care; employment and economic stability; transportation and independence; treatment and medication adherence; interactions with the healthcare system; perceived power imbalance and stigma; and trust and future care decisions. In every theme, lower-SES participants reported a more significant number of - and more disruptive - barriers than higher-SES participants. They described issues regarding obtaining transport and medicines, navigating opaque benefit systems, lacking dependable social support, limited access to specialist care, and feeling dismissed or stigmatised by clinicians, which eroded trust and prompted disengagement from care. Higher-SES participants, while not immune to challenges, more often mobilised resources to buffer their impact.
Conclusion:
Lower socioeconomic status intensifies financial, informational, and relational barriers to managing epilepsy effectively, undermining adherence and care consistency. Routine SES assessment, tailored education, and integrated social-support interventions are crucial to reduce these inequities and improve outcomes for socioeconomically disadvantaged people with epilepsy.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
05:54Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
Published on: June 13, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists